Domov › Akútna myeloidná leukémia › New Jersey › Edison
Klinické štúdie Akútna myeloidná leukémia v meste Edison, NJ
20 štúdií pre Akútna myeloidná leukémia hľadá účastníkov v zariadeniach v meste Edison a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Prebieha náborFáza 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 míľ odtiaľ
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 míľ odtiaľ
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Prebieha náborFáza 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 míľ odtiaľ
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 míľ odtiaľ
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Prebieha náborFáza 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 míľ odtiaľ
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 míľ odtiaľ
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Prebieha náborFáza 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 míľ odtiaľ
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 míľ odtiaľ
A Study of CRD3874-SI in People With Leukemia
Prebieha náborFáza 1
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 míľ odtiaľ
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Prebieha náborFáza 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 míľ odtiaľ
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 míľ odtiaľ
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Prebieha náborFáza 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 míľ odtiaľ
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 míľ odtiaľ
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Prebieha náborFáza 3
- Saint Peter's University Hospital, New Brunswick · 3 míľ odtiaľ
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 míľ odtiaľ
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Prebieha náborFáza 1/2
- Saint Peter's University Hospital, New Brunswick · 3 míľ odtiaľ
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 míľ odtiaľ
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Prebieha náborFáza 3
- Rutgers Biomedical and Health Sciences, New Brunswick · 3 míľ odtiaľ
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
Prebieha náborFáza 2
- Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 míľ odtiaľ
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Prebieha náborObservačná štúdia
- Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick · 3 míľ odtiaľ
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
Prebieha náborFáza 1
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 míľ odtiaľ
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
Prebieha náborFáza 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 míľ odtiaľ
A Study of Revumenib and Mezigdomide in People With Leukemia
Prebieha náborFáza 1/2
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 míľ odtiaľ
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
Prebieha náborFáza 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 míľ odtiaľ
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Prebieha náborFáza 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 míľ odtiaľ
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Prebieha náborFáza 1
- Rutgers Cancer Institute, New Brunswick · 3 míľ odtiaľ
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
Prebieha náborFáza 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 míľ odtiaľ
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
Prebieha náborFáza 2
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 míľ odtiaľ
Štúdie Akútna myeloidná leukémia v iných mestách
- Houston, TX85 štúdií
- New York City, NY51 štúdií
- Boston, MA44 štúdií
- Baldwin Park, CA40 štúdií
- Seattle, WA40 štúdií
- Columbus, OH35 štúdií
- Philadelphia, PA34 štúdií
- Durham, NC33 štúdií
- Atlanta, GA30 štúdií
- Tampa, FL29 štúdií
- Chicago, IL26 štúdií
- Portland, OR25 štúdií
Iné štúdie v Edison
- Rakovina prsníka68 štúdií
- Nemalobunkový karcinóm pľúc47 štúdií
- Rakovina (všetky typy)33 štúdií
- Rakovina prostaty29 štúdií
- Kolorektálny karcinóm23 štúdií
- Rakovina pľúc23 štúdií
- Mnohonásobný myelóm22 štúdií
- Rakovina močového mechúra21 štúdií
- Metastatická rakovina20 štúdií
- Rakovina vaječníkov20 štúdií
- Rakovina endometria19 štúdií
- Uroteliálny (prechodnobunkový) karcinóm18 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.